Skip to main content

News Archive

News Archive - School of Medicine

Journalist Mark Johnson to Discuss “Dirty Game of Doping in Sports” at Geisel Library, Oct. 20

October 3, 2016

Sports journalist and University of California San Diego alumnus Mark Johnson will take guests inside the metaphorical locker room to share the real dope on doping in professional sports, the focus of his new book, published in July 2016.

MicroRNA Specifically Kills Cancer Cells with Common Mutation

October 2, 2016

Approximately 20 percent of all human cancers have mutations in a gene called KRAS. KRAS-mutant cancers are among the most difficult to treat, with poor survival and resistance to chemotherapy. Researchers at University of California San Diego School of Medicine and Moores Cancer Center used microRNAs to systematically inhibit thousands of other genes to find combinations that are specifically lethal to cancer cells driven by a KRAS mutation.

UC San Diego’s Samara Reck-Peterson Awarded Howard Hughes Medical Institute-Simons Grant

September 27, 2016

The Howard Hughes Medical Institute (HHMI), the Simons Foundation and the Bill & Melinda Gates Foundation has named Samara Reck-Peterson, PhD, an HHMI-Simons Faculty Scholar. Reck-Peterson, a professor in the Department of Cellular and Molecular Medicine and Division of Biological Sciences at University of California San Diego, will receive a total of $1.5 million over five years in support of her studies on cargo transport within cells.

UC San Diego Innovators Earn Biocom Life Science Catalyst Awards

September 27, 2016

Biocom has announced the winners of its inaugural Life Science Catalyst Awards, presented in conjunction with the San Diego Venture Group, and UC San Diego-related innovators are prominent among the awardees.

Researchers Find Fertility Genes Required for Sperm Stem Cells

September 27, 2016

The underlying cause of male infertility is unknown for 30 percent of cases. In a pair of new studies, researchers at University of California San Diego School of Medicine determined that the reproductive homeobox (RHOX) family of transcription factors — regulatory proteins that activate some genes and inactivate others — drive the development of stem cells in the testes in mice. The investigators also linked RHOX gene mutations to male infertility in humans.

Lights, Camera, Action: New Catheter Lets Doctors See Inside Arteries for First Time

September 26, 2016

Removing plaque from clogged arteries is a common procedure that can save and improve lives. This treatment approach was recently made even safer and more effective with a new, high-tech catheter that allows cardiologists to see inside the arteries for the first time, cutting out only the diseased tissue. Interventional cardiologists at Sulpizio Cardiovascular Center at UC San Diego Health are the first in the region to use this technology.

UC San Diego is World’s 7th Best Public University, According to Times Higher Education

September 23, 2016

The University of California San Diego has been ranked the seventh best public university across the globe by Times Higher Education World University Rankings. In its 2016–17 report, the London-based publication ranked UC San Diego 22nd in the United States and 41st internationally.

Science Can Shape Healthy City Planning

September 23, 2016

A three-part series published in The Lancet and released in conjunction with the United Nations quantifies health gains achieved if cities were designed so that shops, facilities, work and public transportation were within walking distance of most residents. In part three of the series published Sept. 23, 2016, researchers tackle how to implement timely research into city design, planning and policy to improve the health of a city’s residents.

Debashis Sahoo: From Computers to Cancer Genomes

September 23, 2016

Prof. Sahoo – whose journey into the world of cancer genomics was borne from his background in computer science – has been selected as a participating member of the Cancer Genomes and Networks program at UC San Diego Moores Cancer Center.

At Bat Against Rare Blood Cancers

September 20, 2016

University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials planned for 2017.
Category navigation with Social links